High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis-Reference-Cited by-同舟云学术

High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis

Published:2018-06 Issue:6 Volume:71 Page:325-331
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Favari Elda,Thomas Michael J.,Sorci-Thomas Mary G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference76 articles.

1. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study;Castelli;Circulation.,1977

2. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease;Miller;Lancet.,1975

3. Novel HDL-directed pharmacotherapeutic strategies;Degoma;Nat Rev Cardiol.,2011

4. HDL-cholesterol and cardiovascular disease: rethinking our approach;Siddiqi;Curr Opin Cardiol.,2015

5. HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target;Bhatt;Curr Atheroscler Rep.,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obeticholic acid's effect on HDL function in MASH varies by diabetic status;Lipids;2024-07-16

2. The Mechanism of Lipoprotein in Atherosclerosis in Patients with Type 2 Diabetes and Coronary Heart Disease;Advances in Clinical Medicine;2024

3. Enhancement of Anti-inflammatory Effects of Synthetic High-Density Lipoproteins by Incorporation of Anionic Lipids;Molecular Pharmaceutics;2023-10-02

4. Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case–control study;Scientific Reports;2023-05-24

5. The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors;Cancer Immunology, Immunotherapy;2023-02-24